Position in ACAD
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$44,520
-$8,900 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nemes Rush Group LLC holds $2,865,515 across 18 Biotechnology names. ACAD ranks #4 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,605 | $2,502,856 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
5,168 | $168,166 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
2,019 | $67,071 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
2,000 | $44,520 | |
| 5 | SLS |
SELLAS Life Sciences Group, Inc.
|
10,000 | $42,300 | |
| 6 | CRMD |
CorMedix Inc.
|
2,000 | $13,580 | |
| 7 | DNLI |
Denali Therapeutics Inc.
|
700 | $13,440 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8 | $6,181 |
All Filings in ACAD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,520 | 2,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $53,420 | 2,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $42,680 | 2,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $43,140 | 2,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $33,220 | 2,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $36,700 | 2,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $30,760 | 2,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $32,500 | 2,000 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $36,980 | 2,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $62,620 | 2,000 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $41,680 | 2,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $47,900 | 2,000 | Shares | Sole | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||